Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. Understanding how to discern reliable sources, interpret research methodologies, and apply key findings to real-world scenarios can be daunting.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. This Epilepsy – Pipeline Insight, 2021 provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Epilepsy pipeline landscape.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52

Cannabis Law Report

JULY 27, 2021

and its Scientific Advisory Board, the Organization Publishes New Real-World Study on Epilepsy and CBD. –(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has appointed Nicolas Schlienz, Ph.D., as its Research Director, a new role in the organization’s leadership.

Data 105

Data Epilepsy Research and Development Clinical Trials 105

Cannabis Law Report

SEPTEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, has acquired the exclusive worldwide rights from Nanomerics Ltd. Mack, Chairman and CEO of Virpax.

Epilepsy 52

Epilepsy Research and Development Clinical Trials Chronic Pain 52

Veriheal

FEBRUARY 24, 2021

Unfortunately, this had a powerful impact on a small subset of residents—UK children suffering from epilepsy who had been dependent on imported medications to help control their illness. But for some children, especially those struggling to manage severe epilepsy, cannabis and cannabis-based medications have proven to be a powerful tool.

Epilepsy 52

Epilepsy Oil Research and Development Topical 52

Cannabis Law Report

JULY 13, 2021

Australia’s Victorian government says Agriculture Victoria Research scientists have developed the world’s most complete medicinal cannabis genomic reference. The organisation has been licensed by the Australian Government to undertake medicinal cannabis research. Hemp Gazette reports. Source: [link].

Medicine 105

Medicine Research and Development Agriculture Compliance 105

Cannabis Law Report

DECEMBER 3, 2021

We look forward to sharing clinical trial data supporting the potential of ganaxolone to treat a range of seizure disorders as well as research data highlighting the impact that seizures can have on developmental progressions and quality of life in children with CDD.”. Chief Executive Officer of Marinus Pharmaceuticals. “We for placebo.

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

MMJ Recs

NOVEMBER 20, 2023

These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. Additionally, they may help slow the growth of certain types of cancer cells, though further research is needed.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

Cannabis Law Report

JANUARY 15, 2019

British firm GW Pharmaceuticals is licking its wounds after US judges tossed out its attempt to patent multiple cannabinoids for epilepsy treatment following an eight-year battle. The patent, which has been embroiled in dispute since 2010, is for “the use of one or more cannabinoids in the treatment of epilepsy”.

Epilepsy 71

Epilepsy Cannabinoids Treatment Research and Development 71

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Today (30 May) at 09.30 Effective, most effective in treatment Relieve symptoms.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

The Herb Collective

MARCH 1, 2024

This versatile plant, which has been both vilified and celebrated throughout history, is finally getting the recognition it deserves in various sectors, including medicine, wellness, and sustainable development. Cannabidiol (CBD), one of the many compounds found in cannabis, has been at the forefront of this revolution.

Research and Development 105

Research and Development Chronic Pain Medicine History 105

Medicinal Marijuana Association

AUGUST 27, 2019

Extensive research in the United States and England on cannabis in the 1930s came to a halt with the beginning of World War II and did not pick up again afterwards due to the various laws and regulations that classified the plant as a drug.Legal issuescontinued to inhibit serious study until half a century ago, when Prof.

Research and Development 66

Research and Development Clinical Trials Patients Epilepsy 66

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We This product candidate is being funded through a Cooperative Research and Development Agreement (CRADA) with the National Center for Advancing Translational Sciences (NCATS).

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS IND-enabling studies for Envelta are being performed under a Cooperative Research and Development Agreement (CRADA) with NCATS entered into by Virpax in August of 2020. “We

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

PrestoDoctor

SEPTEMBER 26, 2023

Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. It’s important to note that not everyone who uses cannabis will develop mental health issues. Research suggests that there is indeed a link between cannabis use and mental health issues.

Research and Development 105

Research and Development Chronic Pain Sleep Conditions 105

LifeCannMD

FEBRUARY 27, 2024

The Science Behind Medical Marijuana and Its Effects on Epileptic Seizures Medical Marijuana has garnered significant attention for its benefits in treating epilepsy and seizures. Inflammation in the brain is thought to contribute to the development and persistence of seizures.

Clinical Trials 59

Clinical Trials Epilepsy Marijuana Research and Development 59

Cannabis Law Report

OCTOBER 12, 2019

There have recently been a series of developments advancing the Australian medicinal cannabis industry. Key Developments. Key developments include: Permitting the export of Australian manufactured medicinal cannabis products , subject to local demand. Background. What’s next? Source: [link].

Medicine 40

Medicine Research and Development Cultivation Legislation 40

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

United Patients Group

JULY 7, 2023

While there is still much research to be done on the potential benefits and risks of medical cannabis, there is a growing body of evidence that suggests it can be a valuable tool for managing chronic pain, anxiety and depression, nausea and vomiting, seizures, inflammation, sleep, and other health conditions.

Chronic Pain 105

Chronic Pain Sleep Epilepsy Conditions 105

MGC Pharma

APRIL 4, 2018

A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. CBD-based treatment for people with Refractory Epilepsy?—?is Refractory Epilepsy is epilepsy that involves frequent and severe seizures that are difficult to treat. CannEpil™?—?CBD-based

Epilepsy 100

Epilepsy Pharmaceutical Research and Development CBD 100

United Patients Group

AUGUST 1, 2023

Additionally, studies have shown that medical cannabis can help reduce the risk of developing chronic diseases associated with inflammation. Furthermore, recent studies have suggested that CBD can help in the management of seizures, making it a potential treatment option for individuals with epilepsy.

Epilepsy 52

Epilepsy Sleep Chronic Pain Research and Development 52

Veriheal

MARCH 6, 2024

The HSS also pointed out studies with weaker evidence suggesting cannabis can potentially help with conditions like PTSD , epilepsy , and anxiety. The other big change that comes with rescheduling is an increase in cannabis research opportunities. Cannabis use has a low potential to cause physical or psychological dependence.

Research and Development 62

Research and Development DEA Chronic Pain Business 62

MMJ Recs

FEBRUARY 18, 2024

As society re-evaluates its stance on cannabis, a growing body of research is uncovering the therapeutic potential of this plant. Research has identified cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol) as key players in the plant’s therapeutic effects.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

The Herb Collective

AUGUST 1, 2023

While the exact mechanisms behind this phenomenon are still being researched, the results are promising. Effective Against Epilepsy: Cannabis Indica has been found to have powerful effects when used as a treatment for epilepsy.

Indica 87

Indica Blood Pressure Epilepsy Sleep 87

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Food and Drug Administration (“FDA”). The studies are expected to begin in January of 2022.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Puff Puff Post

OCTOBER 3, 2019

Previous success from treating epilepsy with Cannabinoids now motivates doctors to investigate the plant’s effectiveness in treating symptoms of autism. In a 47 acre greenhouse – close to the size of 42 football fields – GW is developing and delivering strains of medicinal cannabis.

Research and Development 94

Research and Development Epilepsy Clinical Trials Treatment 94

Cannabis Law Report

JULY 2, 2021

Research Cluster with expert faculty members from various fields, as well as the first and only Drug Dependence Research Center in the country which is certified by the World Health Organization (WHO) Collaborating Center for Research and Training in Drug Dependence. Find investment partners and move ahead.

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

MMJ Recs

NOVEMBER 17, 2023

Licensing fees, taxes, and other revenue sources associated with MMJ operations generate income that can be reinvested in public services, healthcare initiatives, and community development. Promoting Research and Innovation The medical marijuana industry promotes research and innovation in the field of cannabis-based therapies.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

LifeCannMD

SEPTEMBER 30, 2024

He developed an interest in exploring the therapeutic benefits of cannabis during the initial stages of his career and has since focused on researching its various medical uses. “There’s still a lot of stigma and misinformation surrounding cannabis,” Dr. Sende notes.

Marijuana 52

Marijuana Research and Development Chronic Pain Conditions 52

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

United Patients Group

JULY 29, 2024

Research has also shown that cannabis contains terpenes , aromatic compounds that contribute to its therapeutic effects. Understanding the synergy between these elements is crucial for developing a holistic approach to health. It is also vital to consider dosage and delivery methods to ensure optimal results.

Research and Development 52

Research and Development Strains Chronic Pain Medicine 52

SpeedWeed

AUGUST 9, 2021

The first supply of medical cannabis for pediatric patients with epilepsy at the Buenos Aires National Children’s Garrahan Hospital was finally delivered. It’s for patients with drug-resistant epilepsy, which is when an individual can’t remain seizure-free after two trials of antiseizure medications. . Shutterstock. It modified Law No.

Epilepsy 52

Epilepsy Research and Development Medicine Patients 52

MMJ Recs

JULY 5, 2024

Understanding THC’s mechanisms and clinical implications is crucial as researchers continue to uncover its therapeutic potential and limitations in medical settings. Neurological Disorders Research suggests THC may benefit neurological conditions such as epilepsy, multiple sclerosis (MS), and Parkinson’s disease.

THC 52

THC Research and Development Chronic Pain Cannabinoids 52

Leaf Science

FEBRUARY 19, 2019

When using mice who had been selectively bred to develop symptoms associated with depression (such as lethargy and immobility), researchers found that CBD treatment was linked to a reduction in immobility during a forced swim test, a commonly used test used to study depressive symptoms. CBD and Traditional Antidepressants.

CBD 101

CBD Research and Development Treatment Epilepsy 101

The Joint Blog

JANUARY 12, 2020

However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. You’d be astounded by the analysis we’ve seen of products on the shelf with virtually no CBD in them,” said Cornell University veterinary researcher Joseph Wakshlag: He studies therapeutic uses for the compound.

Pets 36

Pets CBD Clinical Trials Research and Development 36